Paediatric familial hypercholesterolaemia screening in Europe:
public policy background and recommendations

J 2022

Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations

GIDDING, Samuel S., Albert WIEGMAN, Urh GROSELJ, Tomáš FREIBERGER, Noel PERETTI et. al.

Základní údaje

Originální název

Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations

Autoři

GIDDING, Samuel S. (garant), Albert WIEGMAN, Urh GROSELJ, Tomáš FREIBERGER (203 Česká republika, domácí), Noel PERETTI, Kanika I DHARMAYAT, Magdalena DACCORD, Nicola BEDLINGTON, Jaka SIKONJA, Kausik K RAY, Raul D SANTOS, Martin HALLE, Lale TOKGOZOGLU, Inaki GUTIERREZ-IBARLUZEA, Fausto J PINTO a Marius GEANTA

Vydání

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, OXFORD, OXFORD UNIV PRESS, 2022, 2047-4873

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 8.300

Kód RIV

RIV/00216224:14110/22:00127655

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1093/eurjpc/zwac200

UT WoS

000860847200001

Klíčová slova anglicky

Cholesterol; Familial hypercholesterolaemia; Myocardial infarction; Preventive cardiology; LDL cholesterol

Štítky

14110114, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 16. 1. 2023 13:28, Mgr. Tereza Miškechová

Anotace

V originále

Familial hypercholesterolaemia (FH) is under-recognized and under-treated in Europe leading to significantly higher risk for premature heart disease in those affected. As treatment beginning early in life is highly effective in preventing heart disease and cost-effective in these patients, screening for FH is crucial. It has therefore now been recognized by the European Commission Public Health Best Practice Portal as an effective strategy. Model programmes exist in Europe to identify young individuals with FH, which are based on cascade screening of first-degree relatives of affected individuals, universal screening for high cholesterol, opportunistic screening of high-risk individuals, or a combination of the above approaches. Recommendations presented herein to improve identification of FH emphasize that every country should have an FH screening programme. These programmes should be adapted from existing strategies to best fit the individual country's healthcare system, governments should provide financial support for these programmes and related care, and further research to optimize care and implementations should be conducted.

Návaznosti

LX22NPO5104, projekt VaV

Název: Národní institut pro výzkum metabolických a kardiovaskulárních onemocnění (Akronym: CarDia)

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Národní institut pro léčbu metabolických a kardiovaskulárních onemocnění, 5.1 EXCELES

Přiložené soubory

Paediatric_familial_hypercholesterolaemia_screening_in_Europe_public_policy_background_and_recommendations.pdf

Vyhledat podobné dokumenty

Citovat

GIDDING, Samuel S., Albert WIEGMAN, Urh GROSELJ, Tomáš FREIBERGER, Noel PERETTI, Kanika I DHARMAYAT, Magdalena DACCORD, Nicola BEDLINGTON, Jaka SIKONJA, Kausik K RAY, Raul D SANTOS, Martin HALLE, Lale TOKGOZOGLU, Inaki GUTIERREZ-IBARLUZEA, Fausto J PINTO a Marius GEANTA. Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. OXFORD: OXFORD UNIV PRESS, 2022, roč. 29, č. 18, s. 2301-2311. ISSN 2047-4873. Dostupné z: https://dx.doi.org/10.1093/eurjpc/zwac200.

@article{2243399,
   author = {Gidding, Samuel S. and Wiegman, Albert and Groselj, Urh and Freiberger, Tomáš and Peretti, Noel and Dharmayat, Kanika I and Daccord, Magdalena and Bedlington, Nicola and Sikonja, Jaka and Ray, Kausik K and Santos, Raul D and Halle, Martin and Tokgozoglu, Lale and GutierrezandIbarluzea, Inaki and Pinto, Fausto J and Geanta, Marius},
   article_location = {OXFORD},
   article_number = {18},
   doi = {http://dx.doi.org/10.1093/eurjpc/zwac200},
   keywords = {Cholesterol; Familial hypercholesterolaemia; Myocardial infarction; Preventive cardiology; LDL cholesterol},
   language = {eng},
   issn = {2047-4873},
   journal = {EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY},
   title = {Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations},
   url = {https://academic.oup.com/eurjpc/article/29/18/2301/6691825?login=false},
   volume = {29},
   year = {2022}
}

TY  - JOUR
ID  - 2243399
AU  - Gidding, Samuel S. - Wiegman, Albert - Groselj, Urh - Freiberger, Tomáš - Peretti, Noel - Dharmayat, Kanika I - Daccord, Magdalena - Bedlington, Nicola - Sikonja, Jaka - Ray, Kausik K - Santos, Raul D - Halle, Martin - Tokgozoglu, Lale - Gutierrez-Ibarluzea, Inaki - Pinto, Fausto J - Geanta, Marius
PY  - 2022
TI  - Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations
JF  - EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY
VL  - 29
IS  - 18
SP  - 2301-2311
EP  - 2301-2311
PB  - OXFORD UNIV PRESS
SN  - 20474873
KW  - Cholesterol
KW  - Familial hypercholesterolaemia
KW  - Myocardial infarction
KW  - Preventive cardiology
KW  - LDL cholesterol
UR  - https://academic.oup.com/eurjpc/article/29/18/2301/6691825?login=false
N2  - Familial hypercholesterolaemia (FH) is under-recognized and under-treated in Europe leading to significantly higher risk for premature heart disease in those affected. As treatment beginning early in life is highly effective in preventing heart disease and cost-effective in these patients, screening for FH is crucial. It has therefore now been recognized by the European Commission Public Health Best Practice Portal as an effective strategy. Model programmes exist in Europe to identify young individuals with FH, which are based on cascade screening of first-degree relatives of affected individuals, universal screening for high cholesterol, opportunistic screening of high-risk individuals, or a combination of the above approaches. Recommendations presented herein to improve identification of FH emphasize that every country should have an FH screening programme. These programmes should be adapted from existing strategies to best fit the individual country's healthcare system, governments should provide financial support for these programmes and related care, and further research to optimize care and implementations should be conducted.
ER  -

GIDDING, Samuel S., Albert WIEGMAN, Urh GROSELJ, Tomáš FREIBERGER, Noel PERETTI, Kanika I DHARMAYAT, Magdalena DACCORD, Nicola BEDLINGTON, Jaka SIKONJA, Kausik K RAY, Raul D SANTOS, Martin HALLE, Lale TOKGOZOGLU, Inaki GUTIERREZ-IBARLUZEA, Fausto J PINTO a Marius GEANTA. Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations. \textit{EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY}. OXFORD: OXFORD UNIV PRESS, 2022, roč.~29, č.~18, s.~2301-2311. ISSN~2047-4873. Dostupné z: https://dx.doi.org/10.1093/eurjpc/zwac200.

Podrobný výpis o publikaci